Please see attached the quarterly activities relating to New Zealand Oil & Gas for quarter ending March 31st 2023.
Osmium pair pulls plug on board push.
Cash earnings were flat, and net interest margin rose slightly.
The pharmaceutical firm is pushing for approval of multiple phase-three trials in 2026.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details